Biopharma firm wraps enrollment for Phase II COVID-19 study
RedHill Biopharma has completed enrollment for its Phase II study exploring the use of opaganib in treating COVID-19 patients that have severe pneumonia.
Archives for November 19, 2020
Medidata synthetic control arm lands FDA approval for cancer trial
The control arm, engineered from historical trial data derived from more than 22,000 previous studies, will be used in a Phase III cancer trial.